103711-23-5

Basic information

• Product Name: α-<(tert-butyloxycarbonyl)amino>-N^α-(benzyloxycarbonyl)glycine
• Synonyms: α-<(tert-butyloxycarbonyl)amino>-N^α-(benzyloxycarbonyl)glycine
• CAS NO: 103711-23-5
• Molecular Weight: 324.334
• Mol File: 103711-23-5.mol

Chemical Properties

• CAS DataBase Reference: α-<(tert-butyloxycarbonyl)amino>-N^α-(benzyloxycarbonyl)glycine(CAS DataBase Reference)
• NIST Chemistry Reference: α-<(tert-butyloxycarbonyl)amino>-N^α-(benzyloxycarbonyl)glycine(103711-23-5)
• EPA Substance Registry System: α-<(tert-butyloxycarbonyl)amino>-N^α-(benzyloxycarbonyl)glycine(103711-23-5)

Safety Data

• Hazardous Substances Data: 103711-23-5(Hazardous Substances Data)

Upstream product

• 7682-49-7 N^α-(carbobenzyloxy)-α-carbethoxyglycine 
• 501-53-1 benzyl chloroformate 
• 160380-85-8 α-azido-N-(benzyloxycarbonyl)glycine methyl ester 
• 160380-86-9 α-azido-N-(tert-butoxycarbonyl)glycine methyl ester 
• 150749-03-4 methyl 2-(tert-butoxycarbonylamino)-2-hydroxyacetate 
• 103711-29-1 Amino-tert-butoxycarbonylamino-acetic acid methyl ester 
• 79002-45-2 N-benzyloxycarbonyl-glycine 
• 127357-38-4 N-(benzyloxycarbonyl)-α-hydroxy-glycine methyl ester 
• 255869-50-2 N-Benzyloxycarbonyl-2-carboxamidoglicine ethyl ether 
• 264913-43-1 Ethyl 2-(N-benzyloxycarbonylamino)-2-tert-butoxycarbonylaminoethanoate 
• 4248-19-5 tert-butyl carbazate 
• 103711-22-4 α-(Isopropylthio)-Nα-(benzyloxycarbonyl)glycine 
• 103711-24-6 α-(tert-butyloxycarbonylamino)-N^α-(benzyloxycarbonyl)glycine methyl ester 

Downstream Products

• 173459-81-9 3-(benzyloxycarbonyl-amino)-5-pyridin-3-yl-1,3-dihydro-benzo[e][1,4]diazepin-2-one 
• 152665-84-4 1,3-dihydro-5-(pyridin-2-yl)-3(R,S)-[(benzyloxycarbonyl)-amino]-2H-1,4-benzodiazepin-2-one 
• 1053254-12-8 (2-Oxo-5-phenyl-2,3-dihydro-1H-pyrido[4,3-e][1,4]diazepin-3-yl)-carbamic acid benzyl ester 
• 1056885-00-7 (2-Oxo-5-phenyl-2,3-dihydro-1H-pyrido[3,4-e][1,4]diazepin-3-yl)-carbamic acid benzyl ester 
• 152665-87-7 1,3-Dihydro-5-(pyridin-4-yl)-3(R,S)-[(benzyloxycarbonyl)-amino]-2H-1,4-benzodiazepin-2-one 
• 1055963-39-7 {Amino-[2-(pyridine-4-carbonyl)-phenylcarbamoyl]-methyl}-carbamic acid benzyl ester 
• 1057654-48-4 [Amino-(3-benzoyl-pyridin-2-ylcarbamoyl)-methyl]-carbamic acid benzyl ester 
• 1061237-11-3 [Amino-(3-benzoyl-pyridin-4-ylcarbamoyl)-methyl]-carbamic acid benzyl ester 
• 1061237-45-3 {Amino-[2-(pyridine-3-carbonyl)-phenylcarbamoyl]-methyl}-carbamic acid benzyl ester 
• 1052665-90-3 {Amino-[2-(pyridine-2-carbonyl)-phenylcarbamoyl]-methyl}-carbamic acid benzyl ester 
• 1052716-77-4 (1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-pyrido[2,3-e][1,4]diazepin-3-yl)-carbamic acid benzyl ester 
• 1056019-80-7 (1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-pyrido[4,3-e][1,4]diazepin-3-yl)-carbamic acid benzyl ester 
• 1057653-92-5 (1-Methyl-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-carbamic acid benzyl ester 
• 280568-19-6 (1-Methyl-2-oxo-5-pyridin-3-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-carbamic acid benzyl ester 

Relevant articles and documents

The synthesis and conformational aspects of a novel dioxopiperazine - A possible β-turn constraint

The synthesis and conformational aspects of a dioxopiperazine was discussed. The cis configuration of the dioxopiperazine was rationalized using nuclear magnetic resonance (NMR) spectroscopy. Computational energy calculations were performed to explain the reluctance to cyclise of N-terminal partially protected dipeptides containing α, α-amino groups.

Synthesis of differently protected α-aminoglycines and their peptide derivatives

Compatibly protected α-aminoglycine and di- and tripeptides containing it are prepared from the corresponding α-hydroxyglycines.